Insel Gruppe AG
π¨πSwitzerland
- Country
- π¨πSwitzerland
- Ownership
- Private
- Established
- 2016-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- https://www.inselgruppe.ch
Resting Energy Expenditure in Postmenopausal Women
Not yet recruiting
- Conditions
- PostmenopauseEnergy ExpenditureHormone Replacement Therapy
- First Posted Date
- 2025-04-02
- Last Posted Date
- 2025-04-02
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Target Recruit Count
- 37
- Registration Number
- NCT06905886
- Locations
- π¨π
University Hospital of Bern, Switzerland; Department of Gynecological Endocrinology and Reproductive Medicine, Bern, Switzerland
Influenza Vaccine Elicited Immune Response in Immunocompromised Patients
Completed
- Conditions
- Influenza VaccineImmunocompromised Patients
- Interventions
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-03-26
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Target Recruit Count
- 147
- Registration Number
- NCT06738082
- Locations
- π¨π
Universitsy Hospital Bern, Bern, Switzerland
Short-term Exposure to High Altitude in Patients With Asymptomatic Aortic Stenosis
Not Applicable
Recruiting
- Conditions
- Aortic StenosisAltitude
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Target Recruit Count
- 60
- Registration Number
- NCT06894550
- Locations
- π¨π
University Hospital Inselspital, Bern, Bern, Switzerland
PHArmacotherapy Assessed Using Neuroprobing With TransOsseal Magnetic Stimulation
Recruiting
- Conditions
- Epilepsy
- First Posted Date
- 2025-03-24
- Last Posted Date
- 2025-03-24
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Target Recruit Count
- 40
- Registration Number
- NCT06892457
- Locations
- π¨π
University Hospital Bern, Bern, Switzerland
Dietary Treatment Strategies and Metabolic Control in Glycogen Storage Disease Type I
Not Applicable
Recruiting
- Conditions
- Glycogen Storage Disease Type I
- First Posted Date
- 2025-02-28
- Last Posted Date
- 2025-04-24
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Target Recruit Count
- 20
- Registration Number
- NCT06852612
- Locations
- π¨π
Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Inselspital, Bern University Hospital, Bern, Switzerland
The Interplay Between Moral Distress, Moral Resilience, and Mental Health Outcomes Among Neonatal Care Providers
Recruiting
- Conditions
- Moral Distress
- First Posted Date
- 2025-02-20
- Last Posted Date
- 2025-02-20
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Target Recruit Count
- 800
- Registration Number
- NCT06836323
- Locations
- π¨π
Neonatologie, Inselspital, Bern, Switzerland
Surrogating Physician-recorded SCORE2 Risk Calculator Inputs by Using Auxiliary Data
Recruiting
- Conditions
- Cardiovascular DiseasesMenopause
- First Posted Date
- 2025-02-18
- Last Posted Date
- 2025-02-18
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Target Recruit Count
- 250
- Registration Number
- NCT06831890
- Locations
- π¨π
University Hospital of Bern, Department of Gynecological Endocrinology & Reproductive Medicine, Bern, Switzerland
Treatment for Giant Cell Arteritis With Tocilizumab and 8 as Compared to 26 Weeks of Prednisone
- First Posted Date
- 2025-02-18
- Last Posted Date
- 2025-02-24
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Target Recruit Count
- 178
- Registration Number
- NCT06833411
- Locations
- π¨π
Department of Rheumatology and Immunology, Inselspital, University of Bern, Bern, Switzerland
The Effect of an App-based Intervention on Quality of Life in Patients With Endometriosis.
Not Applicable
Recruiting
- Conditions
- EndometriosisPainQuality of LifeLife Style
- First Posted Date
- 2025-02-11
- Last Posted Date
- 2025-02-14
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Target Recruit Count
- 308
- Registration Number
- NCT06821217
- Locations
- π¨π
Department of Gynecology and Obstetrics, Women's University Hospital, Inselspital Bern, University of Bern, Bern, Switzerland
ToPanc Trial: Survival After Total Versus Partial Pancreaticoduodenectomy for Adenocarcinoma of the Pancreatic Head, Distal Cholangiocarcinoma, and Ampullary Cancer
Not Applicable
Not yet recruiting
- Conditions
- Pancreatic Cancer
- First Posted Date
- 2025-01-30
- Last Posted Date
- 2025-04-23
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Target Recruit Count
- 170
- Registration Number
- NCT06801899
- Locations
- π¨π
Inselspital, Bern University Hospital, Bern, Switzerland